StockWatch
·
Q2 FY-2027 RESULTS · IFGLEXPOR

IFGL Refractories: consol PAT doubles YoY to ₹25.7 Cr, adjusted ~33%, margins expand

PAT +102.7% YoY · revenue +13.2% · margins expanding

Q2 FY27 resultsIFGLEXPORIFGL Refractories Ltd13 Nov 2026 · 3 min read
Revenue

₹553.14 Cr

+13.2% YoY

PAT (consolidated)

₹25.72 Cr

+102.7% YoY

Net margin

4.63%

+2pp YoY

EPS

₹3.57

IFGL Refractories' consolidated PAT came in at ₹25.7 Cr for Q2 FY27, up ~103% YoY (₹12.7 Cr) and up ~51% QoQ, on consolidated revenue of ₹553.1 Cr (+13.2% YoY, +8.0% QoQ). But the YoY jump flatters the underlying trend: roughly ₹6.7 Cr of the gain comes from goodwill amortisation (from the 2016 IFGL–Monocon merger) running off to nil after March 2026 — a charge the year-ago quarter still carried — and a further chunk from the European subsidiary flipping from a ₹7.36 Cr segment loss a year ago to a ₹0.89 Cr profit this quarter. Stripping these largely non-recurring/structural items out, underlying YoY PAT growth is closer to ~33%, which is the number that should anchor any read of this result — still a genuinely good quarter, not the headline-doubling it first appears.

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹553.14 Cr+8%+13.2%
Expenses₹521.41 Cr+6%+10%
PAT₹25.72 Cr+50.76%+102.7%
Net margin4.63%+1.3pp+2pp
EPS₹3.57+50.6%+102.8%

Margins did expand on an operating basis: consolidated OPM (EBITDA/revenue) rose to 8.83% from 7.77% a year ago and 7.22% last quarter, with NPM up to 4.63% from 2.59% YoY. The expansion sits mainly on raw-material and other-expense lines growing slower than revenue, consistent with better overseas mix (America segment result nearly doubled YoY to ₹10.6 Cr from ₹5.6 Cr) layering on top of the amortisation tailwind. Management's own standing guidance — a double-digit consolidated EBITDA margin and double-digit domestic growth by FY27-end — is on track but not yet fully met: domestic (India) revenue grew 12.2% YoY this quarter to ₹319.7 Cr, clearing the double-digit bar, while H1 domestic growth (9.86%) still trails it; margin at 8.83% is improving but short of the double-digit target. No management press release was available to cross-check tone beyond the filing itself, and no verified street/consensus estimate for this print turned up in search, so vs-street is unknown rather than assumed.

₹
151.6172192.41212.81233.21177.8708-1009-0109-2410-1911-1111-13Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹177.87, down 1.9% over the past month of trading.

₹ Cr
-6.545.3717.2729.1810.81Q1 FY26rev ₹454 Cr12.69Q2 FY26rev ₹489 Cr-3.08Q3 FY26rev ₹469 Cr14.28Q4 FY26rev ₹483 Cr17.06Q1 FY27rev ₹512 Cr25.72Q2 FY27rev ₹553 Cr
Quarterly consolidated PAT, ₹ Crore

For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 3 consecutive quarters; revenue is at a 6-quarter high.

Beyond the headline

What the summary numbers don't show

EPS ₹3.57 consolidated (vs ₹2.37 in Q1 FY27, ₹1.76 in Q2 FY26) — ₹8.32 Cr tax matter (Sec 10AA appeal) remains an unprovided contingent liability pending Calcutta HC.

What management guided (1 FY-2027 call)
Targeting double-digit EBITDA margin on consolidated basis; aiming double-digit domestic growth by year-end. Capex: ₹150–200 Cr upside from new mag carbon brick and casting flux lines at peak capacity.

— This quarter: met

The standalone (India-only) entity tells a steadier story — PAT up 23.3% YoY to ₹18.3 Cr on revenue up 12.7% to ₹323.3 Cr — underscoring that most of the consolidated beat is an overseas/accounting story, not a domestic acceleration; readers comparing the two sets of numbers should not read the gap as an error. Subsequent to the quarter, the company terminated its JV agreement with Marvels International Group (Seychelles) and Marvel Refractories (Anshan) of China effective October 14, 2026, and charged off ₹1.5–1.7 Cr against the related IFGL-Marvels Refractories investment/capex on prudence grounds pending a valuation change — a modest, flagged item that doesn't affect this quarter's core P&L materially.

  • W1

    Whether consolidated EBITDA margin crosses management's double-digit target by FY27-end (8.06% in H1 FY27, 8.83% in Q2 alone).

  • W2

    Resolution/valuation of the IFGL-Marvels Refractories investment following the October 2026 JV termination — carrying value explicitly flagged as 'in the process of being changed'.

  • W3

    Whether India domestic revenue growth holds above the 12.2% Q2 pace through H2 to pull full-year growth past the double-digit guidance mark (H1 currently at 9.86%).

Figures in filing are ₹ Lakh, converted to Cr; both PBT/PAT checks tie out exactly on standalone and consolidated. Goodwill amortisation (₹6.67 Cr/quarter) ceased after Mar-2026 (fully amortised), flattering YoY PBT comparison; Europe segment swung from a ₹7.36 Cr loss to a ₹0.89 Cr profit YoY. ₹1.5–1.7 Cr written off on IFGL-Marvels JV assets post the Oct-2026 JV termination with Marvels International. ₹8.32 Cr tax matter (Sec 10AA) remains a disclosed contingent liability, sub judice at Calcutta HC, unprovided.

Informational and educational content only. Not investment advice.